Niagen Bioscience, Inc. (NAGE)
4.84
+0.11
(+2.33%)
USD |
NASDAQ |
Apr 17, 16:00
4.84
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience Free Cash Flow : 13.14M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| SIGA Technologies, Inc. | 43.12M |
| Nephros, Inc. | 1.645M |
| Clover Health Investments Corp. | -68.98M |
| Corcept Therapeutics, Inc. | 141.78M |
| Protalix Biotherapeutics, Inc. | -13.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.624M |
| Cash from Investing (Quarterly) | -0.101M |
| Cash from Financing (Quarterly) | -0.025M |
| Free Cash Flow Per Share (Quarterly) | 0.0062 |
| Free Cash Flow to Equity (Quarterly) | 0.761M |
| Free Cash Flow to Firm (Quarterly) | 0.523M |
| Free Cash Flow Yield | 3.19% |